-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $86

Benzinga·07/27/2026 17:39:14
Listen to the news
B. Riley Securities analyst William Woods maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target from $55 to $86.